The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Both Canadian Prime Minister Trudeau and Mexican President Sheinbaum said they had agreed to bolster border enforcement ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Bristol Myers Squibb (NYSE:BMY) on Thursday noticed a decline in its stock price. This after saying it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost savings effort to ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

Donald Trump’s spending freeze isn’t supposed to be in effect after a court order, but multiple Head Start programs around ...

The richest man in the world shared the video, clutching at his pearls. “She is breaking the law. Literally. Outright,” he ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Investors bought dollars, sold stocks and fretted about inflation on Monday in a scramble to assess the risk of trade war ...

The Penn Hills Library, 1037 Stotler Road, offers a variety of programs for all ages. For a complete list of offerings, visit ...

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...

With the headquarters of the US Agency for International Development nearly empty on Saturday, a small group of Elon Musk ...